TCI Wealth Advisors’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-100
Closed -$76 2414
2023
Q1
$76 Hold
100
﹤0.01% 2416
2022
Q4
$115 Buy
+100
New +$83 ﹤0.01% 2395
2021
Q2
Sell
-31
Closed 2491
2021
Q1
$0 Buy
+31
New +$698 ﹤0.01% 2258

Other funds holding AFIB

TCI Wealth Advisors's AFIB Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Acutus Medical Inc (AFIB) in Q2 2023, closing a stake of 100 shares — an estimated $76 sold.

TCI Wealth Advisors first reported a position in AFIB in Q1 2021 and held it in 3 quarters. The position peaked at $115 in Q4 2022. 35 funds tracked by Wall St. Rank hold AFIB as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Acutus Medical Inc position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 100 Acutus Medical Inc shares in Q2 2023, an estimated $76.
  • TCI Wealth Advisors first reported a position in Acutus Medical Inc in Q1 2021 and held it in 3 quarters.
  • TCI Wealth Advisors's Acutus Medical Inc position peaked at $115 in Q4 2022.
  • 35 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.